Cargando…

Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function

OBJECTIVE: The underlying mechanisms by which cystatin C affects cardiovascular disease (CVD) are not very clear. Metabolic syndrome (MetS) is a cluster of risk factors that increase the risk of CVD. Here, we aimed to investigate the association of cystatin C with metabolic syndrome and cardiovascul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Qi, Zhao, Ning, Wang, Yuqing, Li, Youmei, Xiang, Chaojun, Li, Lufeng, Zheng, Wei, Xu, Shangcheng, Zhao, Xiao-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601472/ https://www.ncbi.nlm.nih.gov/pubmed/31317040 http://dx.doi.org/10.1155/2019/8541402

Ejemplares similares

The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
por: Mao, Qi, et al.
Publicado: (2019)

Serum cystatin C predicts the risk of non-ST-elevation acute coronary syndrome
por: Dong, Hao, et al.
Publicado: (2023)

Prognostic Value of Plasma Intermedin Level in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
por: Li, Pengyang, et al.
Publicado: (2016)

Prognostic Factors in Patients with Acute Coronary Syndrome without ST-segment Elevation
por: İşcen, Sinan
Publicado: (2013)

Prognostic value of plasma ST2 in patients with non-ST segment elevation acute coronary syndrome
por: Kokkoz, Çağrı, et al.
Publicado: (2018)

Diffuse ST-segment elevation beyond acute coronary syndrome
por: Zhu, Hai, et al.
Publicado: (2023)

Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
por: Liu, Chi, et al.
Publicado: (2022)

Treatment of acute coronary syndrome without ST-segment elevations in the elderly
por: Oliveira, GMM, et al.
Publicado: (2005)

ST-Segment Elevation in the Setting of Diabetic Ketoacidosis: Is It Acute Coronary Syndrome?
por: Wray, Jesse, et al.
Publicado: (2020)

Clinical and prognostic implications of delirium in elderly patients with non–ST-segment elevation acute coronary syndromes
por: Vives-Borrás, Miquel, et al.
Publicado: (2019)

The Incremental Prognostic Value of E/(e’×s’) Ratio in Non-ST-Segment Elevated Acute Coronary Syndrome
por: Ionac, Ioana, et al.
Publicado: (2021)

Cystatin C in the prognostic stratification of patients with an acute coronary syndrome
por: Lago, A Lopez, et al.
Publicado: (2007)

Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Cheng, Chao, et al.
Publicado: (2019)

Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland
por: Boeddinghaus, Jasper, et al.
Publicado: (2020)

Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome
por: Bassan, Fernando, et al.
Publicado: (2016)

ST Segment Elevation in aVR: Clinical Significance in Acute Coronary Syndrome
por: Kossaify, Antoine
Publicado: (2013)

Alcohol Binge Drinking–Induced ST-Segment-Elevation Acute Coronary Syndrome
por: Swarath, Steven, et al.
Publicado: (2022)

Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023)

Long-term prognostic value of macrophage migration inhibitory factor in ST-segment elevation myocardial infarction patients with metabolic syndrome after percutaneous coronary intervention
por: Yu, Xiao-Lin, et al.
Publicado: (2022)

Analysis of Ticagrelor’s Cardio-protective Effects on Patients with ST-segment Elevation Acute Coronary Syndrome Accompanied with Diabetes
por: Li, Dong-Tao, et al.
Publicado: (2019)

Cystatin C in Acute Coronary Syndrome
por: Lodh, Moushumi, et al.
Publicado: (2013)

ST Segment Elevation with Normal Coronaries
por: Sethi, Pooja, et al.
Publicado: (2016)

Prognostic implications of ST‐segment elevation in lead aVR in patients with acute coronary syndrome: A meta‐analysis
por: Wang, Aqian, et al.
Publicado: (2020)

Considering Both GLS and MD for a Prognostic Value in Non-ST-Segment Elevated Acute Coronary Artery Syndrome
por: Ionac, Ioana, et al.
Publicado: (2023)

Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome
por: Gimbel, M. E., et al.
Publicado: (2017)

Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?
por: Chandiramani, Rishi, et al.
Publicado: (2020)

ANMCO POSITION PAPER: Timing of coronary angiography in non-ST-segment elevation acute coronary syndromes
por: Murrone, Adriano, et al.
Publicado: (2021)

Impact of ST-segment elevation on the outcome of Takotsubo syndrome
por: Gietzen, Thorsten, et al.
Publicado: (2019)

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Zhao, Li-Hong, et al.
Publicado: (2022)

Early/Subtle Electrocardiography Features of Acute Coronary Syndrome and ST-Segment Elevation Myocardial Infarction
por: Gunaseelan, R., et al.
Publicado: (2022)

Clinical Features and Prognosis of Patients With Coronary Spasm–Induced Non–ST‐Segment Elevation Acute Coronary Syndrome
por: Nakayama, Naoki, et al.
Publicado: (2014)

Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention
por: Zhao, Xiaoxiao, et al.
Publicado: (2020)

Continuum of Care for Acute Coronary Syndrome: Optimizing Treatment for ST-Elevation Myocardial Infarction and Non–St-Elevation Acute Coronary Syndrome
por: Gibler, W. Brian, et al.
Publicado: (2018)

Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
por: Gąsior, Paweł, et al.
Publicado: (2013)

Long-term clinical outcomes in patients with non-ST-segment Elevation Acute Coronary Syndrome and ST-segment elevation myocardial infarction with thrombolysis in myocardial infarction 0 flow
por: Aarts, Bart R.A., et al.
Publicado: (2023)

Visceral Adiposity Index Plays an Important Role in Prognostic Prediction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
por: Zhao, Qi, et al.
Publicado: (2021)

Double stent loss during multivessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome
por: Hawranek, Michał, et al.
Publicado: (2014)

Non-ST elevation acute coronary syndrome in the elderly
por: Díez-Villanueva, Pablo, et al.
Publicado: (2020)

Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines
por: Candela, Elena, et al.
Publicado: (2018)

Roles of Morris Index on Poor Outcomes in Patients with Non-ST Segment Elevation Acute Coronary Syndrome
por: Lin, Huizhong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u1ovm5num0klh0g49smuro3ni8